Selenium and inflammatory bowel disease

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 309, Issue 2, 2015, Pages G71-G77

  Kudva, Avinash K ^a   Shay, Ashley E ^a   Prabhu, K Sandeep ^a  

^a PENNSYLVANIA STATE UNIVERSITY   (United States)

Author keywords

Cyclooxygenase; Glutathione peroxidase; Prostaglandin; Selenoproteins

Indexed keywords

CHEMOKINE; CYTOKINE; ICOSANOID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; SELENIUM; SELENOCYSTEINE; SELENOPROTEIN; AUTACOID;

COLON CANCER; CROHN DISEASE; DIETARY INTAKE; DISEASE COURSE; HOMEOSTASIS; HUMAN; IMMUNOMODULATION; IMMUNOSTIMULATION; INFLAMMATORY BOWEL DISEASE; INTESTINE FLORA; MACROPHAGE; METABOLITE; MICROBIOME; NONHUMAN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; REVIEW; ULCERATIVE COLITIS; ANIMAL; COLON TUMOR; DIET; IMMUNOLOGY; INTESTINE; METABOLISM; MICROBIOLOGY; MICROFLORA; OXIDATION REDUCTION REACTION; RISK FACTOR; SIGNAL TRANSDUCTION;

ANIMALS; COLONIC NEOPLASMS; DIET; HUMANS; INFLAMMATION MEDIATORS; INFLAMMATORY BOWEL DISEASES; INTESTINES; MICROBIOTA; OXIDATION-REDUCTION; RISK FACTORS; SELENIUM; SELENOPROTEINS; SIGNAL TRANSDUCTION;

EID: 84937469303     PISSN: 01931857     EISSN: 15221547     Source Type: Journal    
DOI: 10.1152/ajpgi.00379.2014     Document Type: Review

References (68)

1. Andoh A, Hirashima M, Maeda H, Hata K, Inatomi O, Tsujikawa T, Sasaki M, Takahashi K, Fujiyama Y. Serum selenoprotein-P levels in patients with inflammatory bowel disease. Nutrition 21: 574–579, 2005.
2. Arteel GE, Mostert V, Oubrahim H, Briviba K, Abel J, Sies H. Protection by selenoprotein P in human plasma against peroxynitritemediated oxidation and nitration. Biol Chem 379: 1201–1205, 1998.
3. Astudillo AM, Pérez-Chacón G, Balboa MA, Balsinde J. Arachidonic acid mobilization by stimuli of the innate immune response. Inmunología 28: 182–192, 2009.
4. Banning A, Deubel S, Kluth D, Zhou Z, Brigelius-Flohe R. The GI-GPx gene is a target for Nrf2. Mol Cell Biol 25: 4914–4923, 2005.
5. Banning A, Florian S, Deubel S, Thalmann S, Muller-Schmehl K, Jacobasch G, Brigelius-Flohe R. GPx2 counteracts PGE2 production by dampening COX-2 and mPGES-1 expression in human colon cancer cells. Antiox Redox Signal 10: 1491–1500, 2008.
6. Barrett CW, Ning W, Chen X, Smith JJ, Washington MK, Hill KE, Coburn LA, Peek RM, Chaturvedi R, Wilson KT, Burk RF, Williams CS. Tumor suppressor function of the plasma glutathione peroxidase gpx3 in colitis-associated carcinoma. Cancer Res 73: 1245–1255, 2013.
7. Berry MJ, Banu L, Chen YY, Mandel SJ, Kieffer JD, Harney JW, Larsen PR. Recognition of UGA as a selenocysteine codon in type I deiodinase requires sequences in the 3= untranslated region. Nature 353: 273–276, 1991.
8. Bjornstedt M, Kumar S, Bjorkhem L, Spyrou G, Holmgren A. Selenium and the thioredoxin and glutaredoxin systems. Biomed Environ Sci 10: 271–279, 1997.
9. Brigelius-Flohe R, Kipp A. Glutathione peroxidases in different stages of carcinogenesis. Biochim Biophys Acta 1790: 1555–1568, 2009.
10. Brigelius-Flohe R, Muller C, Menard J, Florian S, Schmehl K, Wingler K. Functions of GI-GPx: lessons from selenium-dependent expression and intracellular localization. BioFactors 14: 101–106, 2001.
11. Chu FF, Esworthy RS, Doroshow JH. Role of Se-dependent glutathione peroxidases in gastrointestinal inflammation and cancer. Free Rad Biol Med 36: 1481–1495, 2004.
12. Connelly-Frost A, Poole C, Satia JA, Kupper LL, Millikan RC, Sandler RS. Selenium, folate, and colon cancer. Nutr Cancer 61: 165–178, 2009.
13. Conrad M, Schneider M, Seiler A, Bornkamm GW. Physiological role of phospholipid hydroperoxide glutathione peroxidase in mammals. Biol Chem 388: 1019–1025, 2007.
14. Esworthy RS, Aranda R, Martin MG, Doroshow JH, Binder SW, Chu FF. Mice with combined disruption of Gpx1 and Gpx2 genes have colitis. Am J Physiol Gastrointest Liver Physiol 281: G848–G855, 2001.
15. Esworthy RS, Kim BW, Larson GP, Yip ML, Smith DD, Li M, Chu FF. Colitis locus on chromosome 2 impacting the severity of early-onset disease in mice deficient in GPX1 and GPX2. Inflamm Bowel Dis 17: 1373–1386, 2011.
16. Esworthy RS, Swiderek KM, Ho YS, Chu FF. Selenium-dependent glutathione peroxidase-GI is a major glutathione peroxidase activity in the mucosal epithelium of rodent intestine. Biochim Biophys Acta 1381: 213–226, 1998.
17. Florian S, Krehl S, Loewinger M, Kipp A, Banning A, Esworthy S, Chu FF, Brigelius-Flohe R. Loss of GPx2 increases apoptosis, mitosis, and GPx1 expression in the intestine of mice. Free Rad Biol Med 49: 1694–1702, 2010.
18. Florian S, Wingler K, Schmehl K, Jacobasch G, Kreuzer OJ, Meyerhof W, Brigelius-Flohe R. Cellular and subcellular localization of gastrointestinal glutathione peroxidase in normal and malignant human intestinal tissue. Free Rad Res 35: 655–663, 2001.
19. Gandhi UH, Kaushal N, Ravindra KC, Hegde S, Nelson SM, Narayan V, Vunta H, Paulson RF, Prabhu KS. Selenoprotein-dependent up- regulation of hematopoietic prostaglandin D2 synthase in macrophages is mediated through the activation of peroxisome proliferator-activated receptor (PPAR) gamma. J Biol Chem 286: 27471–27482, 2011.
20. Hatfield DL, Gladyshev VN. How selenium has altered our understanding of the genetic code. Mol Cell Biol 22: 3565–3576, 2002.
21. Hiller F, Oldorff L, Besselt K, Kipp AP. Differential acute effects of selenomethionine and sodium selenite on the severity of colitis. Nutrients 7: 2687–2706, 2015.
22. Hrdina J, Banning A, Kipp A, Loh G, Blaut M, Brigelius-Flohe R. The gastrointestinal microbiota affects the selenium status and selenoprotein expression in mice. J Nutr Biochem 20: 638–648, 2009.
23. Irons R, Carlson BA, Hatfield DL, Davis CD. Both selenoproteins and low molecular weight selenocompounds reduce colon cancer risk in mice with genetically impaired selenoprotein expression. J Nutr 136: 1311–1317, 2006.
24. Johtatsu T, Andoh A, Kurihara M, Iwakawa H, Tsujikawa T, Kashiwagi A, Fujiyama Y, Sasaki M. Serum concentrations of trace elements in patients with Crohn’s disease receiving enteral nutrition. J Clin Biochem Nutr 41: 197–201, 2007.
25. Kasaikina MV, Hatfield DL, Gladyshev VN. Understanding selenoprotein function and regulation through the use of rodent models. Biochim Biophys Acta 1823: 1633–1642, 2012.
26. Kasaikina MV, Kravtsova MA, Lee BC, Seravalli J, Peterson DA, Walter J, Legge R, Benson AK, Hatfield DL, Gladyshev VN. Dietary selenium affects host selenoproteome expression by influencing the gut microbiota. FASEB J 25: 2492–2499, 2011.
27. Kaushal N, Kudva AK, Patterson AD, Chiaro C, Kennett MJ, Desai D, Amin S, Carlson BA, Cantorna MT, Prabhu KS. Crucial role of macrophage selenoproteins in experimental colitis. J Immunol 193: 3683–3692, 2014.
28. Kipp A, Banning A, Brigelius-Flohe R. Activation of the glutathione peroxidase 2 (GPx2) promoter by beta-catenin. Biol Chem 388: 1027–1033, 2007.
29. Kipp A, Banning A, van Schothorst EM, Meplan C, Schomburg L, Evelo C, Coort S, Gaj S, Keijer J, Hesketh J, Brigelius-Flohe R. Four selenoproteins, protein biosynthesis, and Wnt signalling are particularly sensitive to limited selenium intake in mouse colon. Mol Nutr Food Res 53: 1561–1572, 2009.
30. Kryukov GV, Castellano S, Novoselov SV, Lobanov AV, Zehtab O, Guigo R, Gladyshev VN. Characterization of mammalian selenoproteomes. Science 300: 1439–1443, 2003.
31. Kuroki F, Matsumoto T, Iida M. Selenium is depleted in Crohn’s disease on enteral nutrition. Dig Dis 21: 266–270, 2003.
32. Lu D, Han C, Wu T. 15-Hydroxyprostaglandin dehydrogenase-derived 15-keto-prostaglandin E2 inhibits cholangiocarcinoma cell growth through interaction with peroxisome proliferator-activated receptorgamma, SMAD2/3, and TAP63 proteins. J Biol Chem 288: 19484–19502, 2013.
33. Martinez FO, Gordon S. The M1 and M2 paradigm of macrophage activation: time for reassessment (Abstract). Prime Rep 6: 13, 2014.
34. Méplan C, Hesketh JE. Selenium and cencer: a story that should not be forgotten-insights from genomics. In: Advances in Nutrition and Cancer, edited by Zappia V, Panico S, Russo GL, Budillon A, and Ragione FD. London, UK: Springer, 2013.
35. Méplan C, Hughes DJ, Pardini B, Naccarati A, Soucek P, Vodickova L, Hlavata I, Vrana D, Vodicka P, Hesketh JE. Genetic variants in selenoprotein genes increase risk of colorectal cancer. Carcinogenesis 31: 1074–1079, 2010.
36. Murawaki Y, Tsuchiya H, Kanbe T, Harada K, Yashima K, Nozaka K, Tanida O, Kohno M, Mukoyama T, Nishimuki E, Kojo H, Matsura T, Takahashi K, Osaki M, Ito H, Yodoi J, Murawaki Y, Shiota G. Aberrant expression of selenoproteins in the progression of colorectal cancer. Cancer Lett 259: 218–230, 2008.
37. Narayan V, Ravindra KC, Liao C, Kaushal N, Carlson BA, Prabhu KS. Epigenetic regulation of inflammatory gene expression in macrophages by selenium. J Nutr Biochem 26: 138–145, 2015.
38. Nelson SM, Lei X, Prabhu KS. Selenium levels affect the IL-4-induced expression of alternative activation markers in murine macrophages. J Nutr 141: 1754–1761, 2011.
39. Papp LV, Lu J, Holmgren A, Khanna KK. From selenium to selenoproteins: synthesis, identity, and their role in human health. Antiox Redox Signal 9: 775–806, 2007.
40. Pelosof L, Yerram SR, Azad NS, Herman JG. GPX3 promoter hypermethylation predicts platinum sensitivity in colorectal cancer cells. In: AACR 104th Annual Meeting 2013, Apr 6–10, 2013, Washington, DC.
41. Rajakariar R, Hilliard M, Lawrence T, Trivedi S, Colville-Nash P, Bellingan G, Fitzgerald D, Yaqoob MM, Gilroy DW. Hematopoietic prostaglandin D2 synthase controls the onset and resolution of acute inflammation through PGD2 and 15-deoxyDelta12 14 PGJ2. Proc Natl Acad Sci USA 104: 20979–20984, 2007.
42. Rakoff-Nahoum S. Why cancer and inflammation? Yale J Biol Med 79: 123–130, 2006.
43. Rannem T, Ladefoged K, Hylander E, Hegnhoj J, Jarnum S. Selenium status in patients with Crohn’s disease. Am J Clin Nutr 56: 933–937, 1992.
44. Ravindra KC, Narayan V, Lushington GH, Peterson BR, Prabhu KS. Targeting of histone acetyltransferase p300 by cyclopentenone prostaglandin Delta(12)-PGJ(2) through covalent binding to Cys(1438). Chem Res Toxicol 25: 337–347, 2012.
45. Reeves MA, Hoffmann PR. The human selenoproteome: recent insights into functions and regulation. Cell Mol Life Sci 66: 2457–2478, 2009.
46. Ruckrich MF, Schlegel W, Jung A. Prostaglandin endoperoxide analogues and prostaglandid D2 as substrates of human placental 15-hydroxy prostaglandin dehydrogenase. FEBS Lett 68: 59–62, 1976.
47. Saito Y, Hayashi T, Tanaka A, Watanabe Y, Suzuki M, Saito E, Takahashi K. Selenoprotein P in human plasma as an extracellular phospholipid hydroperoxide glutathione peroxidase. Isolation and enzymatic characterization of human selenoprotein p. J Biol Chem 274: 2866–2871, 1999.
48. Sartor SKM, Balfour R. Intestinal microbes in inflammatory bowel diseases. Am J Gastroenterol Suppl 1: 15–21, 2012.
49. Schneikert J, Behrens J. The canonical Wnt signalling pathway and its APC partner in colon cancer development. Gut 56: 417–425, 2007.
50. Schoenmakers E, Agostini M, Mitchell C, Schoenmakers N, Papp L, Rajanayagam O, Padidela R, Ceron-Gutierrez L, Doffinger R, Prevosto C, Luan J, Montano S, Lu J, Castanet M, Clemons N, Groeneveld M, Castets P, Karbaschi M, Aitken S, Dixon A, Williams J, Campi I, Blount M, Burton H, Muntoni F, O’Donovan D, Dean A, Warren A, Brierley C, Baguley D, Guicheney P, Fitzgerald R, Coles A, Gaston H, Todd P, Holmgren A, Khanna KK, Cooke M, Semple R, Halsall D, Wareham N, Schwabe J, Grasso L, Beck-Peccoz P, Ogunko A, Dattani M, Gurnell M, Chatterjee K. Mutations in the selenocysteine insertion sequence-binding protein 2 gene lead to a multisystem selenoprotein deficiency disorder in humans. J Clin Invest 120: 4220–4235, 2010.
51. Schomburg L, Schweizer U, Holtmann B, Flohe L, Sendtner M, Kohrle J. Gene disruption discloses role of selenoprotein P in selenium delivery to target tissues. Biochem J 370: 397–402, 2003.
52. Sica A, Mantovani A. Macrophage plasticity and polarization: in vivo veritas. J Clin Invest 122: 787–795, 2012.
53. Speckmann B, Bidmon HJ, Pinto A, Anlauf M, Sies H, Steinbrenner H. Induction of glutathione peroxidase 4 expression during enterocytic cell differentiation. J Biol Chem 286: 10764–10772, 2011.
54. Speckmann B, Gerloff K, Simms L, Oancea I, Shi W, McGuckin MA, Radford-Smith G, Khanna KK. Selenoprotein S is a marker but not a regulator of endoplasmic reticulum stress in intestinal epithelial cells. Free Rad Biol Med 67: 265–277, 2014.
55. Speckmann B, Pinto A, Winter M, Forster I, Sies H, Steinbrenner H. Proinflammatory cytokines down-regulate intestinal selenoprotein P biosynthesis via NOS2 induction. Free Rad Biol Med 49: 777–785, 2010.
56. Speckmann B, Steinbrenner H. Selenium and selenoproteins in inflammatory bowel diseases and experimental colitis. Inflamm Bowel Dis 20: 1110–1119, 2014.
57. Steinbrenner H, Speckmann B, Sies H. Toward understanding success and failures in the use of selenium for cancer prevention. Antiox Redox Signal 19: 181–191, 2013.
58. Sun FF, Armour SB, Bockstanz VR, McGuire JC. Studies on 15- hydroxyprostaglandin dehydrogenase from monkey lung. Advan Prostaglan Thromb Res 1: 163–169, 1976.
59. Takahashi K, Avissar N, Whitin J, Cohen H. Purification and characterization of human plasma glutathione peroxidase: a selenoglycoprotein distinct from the known cellular enzyme. Arch Biochem Biophys 256: 677–686, 1987.
60. Tan M, Li S, Swaroop M, Guan K, Oberley LW, Sun Y. Transcriptional activation of the human glutathione peroxidase promoter by p53. J Biol Chem 274: 12061–12066, 1999.
61. Te Velde AA, Pronk I, de Kort F, Stokkers PC. Glutathione peroxidase 2 and aquaporin 8 as new markers for colonic inflammation in experimental colitis and inflammatory bowel diseases: an important role for H2O2? Eur J Gastroenterol Hepatol 20: 555–560, 2008.
62. Tirosh O, Levy E, Reifen R. High selenium diet protects against TNBSinduced acute inflammation, mitochondrial dysfunction, and secondary necrosis in rat colon. Nutrition 23: 878–886, 2007.
63. van de Wetering M, Sancho E, Verweij C, de Lau W, Oving I, Hurlstone A, van der Horn K, Batlle E, Coudreuse D, Haramis AP, Tjon-Pon-Fong M, Moerer P, van den Born M, Soete G, Pals S, Eilers M, Medema R, Clevers H. The beta-catenin/TCF-4 complex imposes a crypt progenitor phenotype on colorectal cancer cells. Cell 111: 241–250, 2002.
64. Vong L, Ferraz JG, Panaccione R, Beck PL, Wallace JL. A proresolution mediator, prostaglandin D(2), is specifically up-regulated in individuals in long-term remission from ulcerative colitis. Proc Natl Acad Sci USA 107: 12023–12027, 2010.
65. Vunta H, Davis F, Palempalli UD, Bhat D, Arner RJ, Thompson JT, Peterson DG, Reddy CC, Prabhu KS. The anti-inflammatory effects of selenium are mediated through 15-deoxy-Delta12,14-prostaglandin J2 in macrophages. J Biol Chem 282: 17964–17973, 2007.
66. Yan W, Chen X. GPX2, a direct target of p63, inhibits oxidative stress-induced apoptosis in a p53-dependent manner. J Biol Chem 281: 7856–7862, 2006.
67. Zamuner SR, Bak AW, Devchand PR, Wallace JL. Predisposition to colorectal cancer in rats with resolved colitis: role of cyclooxygenase-2- derived prostaglandin d2. Am J Pathol 167: 1293–1300, 2005.
68. Zamun SR, Warrier N, Buret AG, MacNaughton WK, Wallace JL. Cyclooxygenase 2 mediates post-inflammatory colonic secretory and barrier dysfunction. Gut 52: 1714–1720, 2003.